Synopsis
Synopsis
0
CEP/COS
0
VMF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Bendamustin
2. Bendamustine
3. Cytostasan
4. Hydrochloride, Bendamustine
5. Imet 3393
6. Ribomustin
7. Treanda
8. Zimet 3393
1. 3543-75-7
2. Bendamustine Hcl
3. Treanda
4. Ribomustin
5. Cytostasan
6. Sdx-105
7. Bendamustin Hydrochloride
8. Bendeka
9. Imet 3393
10. 4-(5-(bis(2-chloroethyl)amino)-1-methyl-1h-benzo[d]imidazol-2-yl)butanoic Acid Hydrochloride
11. Syb L-0501
12. Ribomustine
13. Treakisym
14. Bendamustine (hydrochloride)
15. 4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic Acid Hydrochloride
16. 97832-05-8
17. Nsc-138783
18. Sdx 105
19. 3543-75-7 (hcl)
20. Sybl-0501
21. 981y8sx18m
22. Levact
23. 4-(5-(bis(2-chloroethyl)amino)-1-methyl-1h-benzo-[d]imidazol-2-yl)butanoic Acid Hydrochloride
24. 4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic Acid;hydrochloride
25. Treanda (tn)
26. 1h-benzimidazole-2-butanoic Acid, 5-(bis(2-chloroethyl)amino)-1-methyl-, Monohydrochloride
27. Bendit
28. Ccris 1864
29. Nsc 138783
30. Cytostosan
31. Innomustine
32. Symbenda
33. Benda
34. Unii-981y8sx18m
35. Treanda Hcl
36. Zimet 33/93
37. Ribomustin (tn)
38. Bendamustine Hydrochloride Injection
39. Vivimusta
40. Inno-p08001
41. Gamma(1-methyl-5-bis(beta-chloraethyl)aminobenzimidazoyl-2)buttersaeurehydrochlorid [german]
42. Schembl18843
43. Mls006010156
44. Sdx-105 (cytostasane) Hcl
45. Chembl1201734
46. Dtxsid40188912
47. Bcpp000348
48. Bcp02107
49. Hy-b0077
50. Tox21_500623
51. Mfcd01658758
52. Nsc138783
53. S1212
54. Akos015951203
55. Ac-1619
56. Bcp9000390
57. Bendamustine Hydrochloride (jan/usan)
58. Bendamustine Hydrochloride [mi]
59. Bendamustine Hydrochloride [usan:jan]
60. Ccg-221927
61. Cs-1771
62. Ep-3101
63. Lp00623
64. Sb17462
65. 2-benzimidazolebutyric Acid, 5-(bis(2-chloroethyl)amino)-1-methyl-, Monohydrochloride
66. 2-benzimidazolinebutryric Acid, 1-methyl-5-bis(2-chloroethyl)amino-, Hydrochloride
67. Bendamustine Hydrochloride [jan]
68. Gamma(1-methyl-5-bis(beta-chloraethyl)aminobenzimidazoyl-2)buttersaeurehydrochlorid
69. Bendamustine Hydrochloride [usan]
70. Ncgc00261308-01
71. As-15856
72. Bb164239
73. Bendamustine Hydrochloride [mart.]
74. Bp-25399
75. Smr004234484
76. Bendamustine Hydrochloride [usp-rs]
77. Bendamustine Hydrochloride [who-dd]
78. Bendamustine Hcl (sdx-105, Cytostasane)
79. 2-benzimidazolinebutryric Acid, Hydrochloride
80. Am20090666
81. B4033
82. Ft-0650624
83. Ft-0696296
84. Sw219266-1
85. 2-benzimidazolebutyric Acid, Monohydrochloride
86. Bendamustine Hydrochloride [orange Book]
87. D07085
88. Wln: T56 Bn Dnj B1 C3vq Gn2g2g &gh
89. 543b757
90. Bendamustine Hydrochloride [usp Monograph]
91. Q27272066
92. Fmoc-(s)-3-amino-3-(3-trifluoromethyl-phenyl)-propionicacid
93. 4-(5-(bis(2-chloroethyl)amino)-1-methylbenzimidazol-2-yl)butanoic Acid Hcl
94. 4-(5-(bis(2-chloroethyl)amino)-1-methyl-1h-benzo[d]imidazol-2-yl)butanoicacidhydrochloride
95. 5-[bis(2-chloroethyl)amino]-1-methyl-1h-benzimidazole-2-butanoic Acid Hydrochloride
96. 5-[bis(2-chloroethyl)amino]-1-methylbenzimidazole-2-butyric Acid Hydrochloride
97. 1h-benzimidazole-2-butanoic Acid, 5-[bis(2-chloroethyl)amino]-1-methyl-, Hydrochloride (1:1)
98. 4-(5-(bis(2-chloroethyl)amino)-1-methyl-1h-benzimidazole-2-yl)butanoic Acid Monohydrochloride
99. 5-[bis(2-chloroethyl)-amino]-1-methyl-1h-benzimidazole-2-butanoic Acid Hydrochloride;ribomustin Hcl
Molecular Weight | 394.7 g/mol |
---|---|
Molecular Formula | C16H22Cl3N3O2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 9 |
Exact Mass | 393.077760 g/mol |
Monoisotopic Mass | 393.077760 g/mol |
Topological Polar Surface Area | 58.4 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 380 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Bendamustine hydrochloride |
PubMed Health | Bendamustine (Injection) |
Drug Classes | Antineoplastic Agent |
Drug Label | TREANDA contains bendamustine hydrochloride, an alkylating drug, as the active ingredient. The chemical name of bendamustine hydrochloride is 1H-benzimidazole-2-butanoic acid, 5-[bis(2-chloroethyl)amino]-1 methyl-,monohydrochloride. Its empirical m... |
Active Ingredient | Bendamustine hydrochloride |
Dosage Form | Injectable |
Route | injection |
Strength | 100mg |
Market Status | Tentative Approval |
Company | Eagle Pharms |
2 of 4 | |
---|---|
Drug Name | Treanda |
Drug Label | TREANDA contains bendamustine hydrochloride, an alkylating drug, as the active ingredient. The chemical name of bendamustine hydrochloride is 1H-benzimidazole-2-butanoic acid, 5-[bis(2-chloroethyl)amino]-1 methyl-,monohydrochloride. Its empirical m... |
Active Ingredient | Bendamustine hydrochloride |
Dosage Form | Powder; Injectable; Solution |
Route | injection; Iv (infusion) |
Strength | 25mg/vial; 180mg/2ml (90mg/ml); 45mg/0.5ml (90mg/ml); 100mg/vial; 100mg |
Market Status | Prescription |
Company | Cephalon |
3 of 4 | |
---|---|
Drug Name | Bendamustine hydrochloride |
PubMed Health | Bendamustine (Injection) |
Drug Classes | Antineoplastic Agent |
Drug Label | TREANDA contains bendamustine hydrochloride, an alkylating drug, as the active ingredient. The chemical name of bendamustine hydrochloride is 1H-benzimidazole-2-butanoic acid, 5-[bis(2-chloroethyl)amino]-1 methyl-,monohydrochloride. Its empirical m... |
Active Ingredient | Bendamustine hydrochloride |
Dosage Form | Injectable |
Route | injection |
Strength | 100mg |
Market Status | Tentative Approval |
Company | Eagle Pharms |
4 of 4 | |
---|---|
Drug Name | Treanda |
Drug Label | TREANDA contains bendamustine hydrochloride, an alkylating drug, as the active ingredient. The chemical name of bendamustine hydrochloride is 1H-benzimidazole-2-butanoic acid, 5-[bis(2-chloroethyl)amino]-1 methyl-,monohydrochloride. Its empirical m... |
Active Ingredient | Bendamustine hydrochloride |
Dosage Form | Powder; Injectable; Solution |
Route | injection; Iv (infusion) |
Strength | 25mg/vial; 180mg/2ml (90mg/ml); 45mg/0.5ml (90mg/ml); 100mg/vial; 100mg |
Market Status | Prescription |
Company | Cephalon |
Antineoplastic Agents, Alkylating
A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026) (See all compounds classified as Antineoplastic Agents, Alkylating.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?